Figure 3.
Correlation between changes in body weight from baseline to 24 weeks after oral semaglutide treatment and those in levels of (a) alanine aminotransferase (ALT) and (b) controlled attenuation parameter (CAP).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.